Carl Zeiss Meditec AG (fra:AFXA) Share Price

Company Profile

Business description
Carl Zeiss Meditec is one of the largest visioncare technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up about 75% of sales in 2025, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
Contact
Goschwitzer Strasse 51-52
JenaTH07745
DEU
T: +49 3641220115
https://www.zeiss.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
30 September 2026
Employees
5,798

Recommended

Sales growth but lack of margin expansion due to competition.

Johannes Faul, CFA | 15 June 2026

Discounted Aussie shares that offer a tax rebate.

Tyger Fitzpatrick | 14 June 2026

Pre-IPO holders could start selling later this summer, and earnings will be an important test.

Tom Lauricella | 14 June 2026

Index	Last price	Change	% Change
All Ordinaries	9,128.00	14.60	0.16%
CAC 40	8,406.66	55.79	0.67%
DAX 40	24,921.59	286.29	1.16%
Dow JONES (US)	51,796.64	594.38	1.16%
FTSE 100	10,426.44	45.28	-0.43%
HKSE	24,842.67	124.57	0.50%
NASDAQ	26,499.32	610.47	2.36%
Nikkei 225	69,317.50	3,297.46	4.99%
NZX 50 Index	13,360.59	33.28	-0.25%
S&P 500	7,541.74	110.28	1.48%
S&P/ASX 200	8,914.00	7.00	0.08%
SSE Composite Index	4,096.47	64.96	1.61%